JNJ is up 1.07% today in the Healthcare sector. Volume is 0.
Johnson & Johnson (NYSE:JNJ) reported breakthrough Phase 2/3 ENERGY trial results for IMAAVY (nipocalimab) in warm autoimmune hemolytic anemia, a rare anemia with no current FDA a…
We recently published Jim Cramer Didn’t Hold Back On SpaceX’s IPO & Discussed These 12 Stocks. Johnson & Johnson (NYSE:JNJ) is one of the stocks discussed by Jim Cramer. Johnson &…
Building $3,000 a month in dividend income before age 50 can transform the way you think about work. While it may not fully replace a salary, it can cover a mortgage payment, heal…
A $2 million dividend portfolio for retirement sounds like you’ve arrived. For a retired couple living in New York, however, the headline portfolio value tells only part of the st…
The average retired worker receives roughly $23,700 per year from Social Security. A $750,000 portfolio dedicated to income generation can surpass that figure at virtually any rea…